Literature DB >> 5812258

Braunwald NS: Treatment of paroxysmal supraventricular trachycardia by electrical stimulation of the carotid-sinus nerves.

E Braunwald, B E Sobel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5812258     DOI: 10.1056/NEJM196910162811607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Demand pacemaker for refractory atrial tachycardia in a patient with aortic regurgitation.

Authors:  U R Shettigar; J F Pfeifer; H N Hultgren
Journal:  West J Med       Date:  1975-11

Review 2.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 3.  The baroreceptor as a therapeutic target for heart failure.

Authors:  Edoardo Gronda; Eric G Lovett; Michela Tarascio; Dimitrios Georgakopoulos; Guido Grassi; Emilio Vanoli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-22       Impact factor: 4.132

4.  Antiarrhythmic agents. II. Therapeutic considerations.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Carotid sinus nerve stimulation in the treatment of angina pectoris and supraventricular tachycardia.

Authors:  E Braunwald; S F Vatner; N S Braunwald; B E Sobel
Journal:  Calif Med       Date:  1970-03

Review 6.  Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.

Authors:  Marcel Halbach; Thorsten Fritz; Navid Madershahian; Roman Pfister; Hannes Reuter
Journal:  Curr Heart Fail Rep       Date:  2016-04

Review 7.  [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].

Authors:  M Halbach; T Fritz; N Madershahian; R Pfister; H Reuter
Journal:  Herz       Date:  2015-11       Impact factor: 1.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.